Our study explored novel targets for the diagnosis and treatment of esophageal cancer by exploring the imbalance between IL-1RA and IL-1A, which leads to tumor-induced lymphangiogenesis, with a stronger basis for clinical transformation. This evidence concerns the gene IL1RN and neoplasm.